Sort
21,453 grants matching “tuberculosis”
High content screening of Mycobacterium tuberculosis
$631,092Tanya Parish · Access To Advanced Health Institute · R01 · FY2018 · AI
Eradicating persistent M. tuberculosis by synthetic lethality of terminal respiratory oxidases
$630,978Michael Berney · Albert Einstein College Of Medicine · R01 · FY2023 · AI
Eradicating persistent M. tuberculosis by synthetic lethality of terminal respiratory oxidases
$630,978Michael Berney · Albert Einstein College Of Medicine · R01 · FY2022 · AI
Host Genetics of HIV-1 Subtype C Infection, Progression, and Treatment in Africa
$630,864Myron E Essex · Harvard School Of Public Health · R01 · FY2007 · AI
Beta-lactamase fluorescent probes for bacterial detection
$630,860Jianghong Rao · Stanford University · R01 · FY2020 · AI
Innate Determinants of Microbial Immunity
$630,791Alan Sher · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Regulation Of Immunopathology In Bacterial And Parasitic Disease
$630,791Alan Sher · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Cell Phone Video Directly Observed Therapy to Monitor Short Course LTBI Treatment
$630,680Richard S Garfein · University Of California, San Diego · U01 · FY2018 · AI
Regulation of T cell homeostasis and memory
$630,664Linda Mac Pherson Bradley · Univ Of Massachusetts Med Sch Worcester · P01 · FY2010 · AI
MmpL3 as a target for novel anti-TB agents
$630,615Mary Jackson · Colorado State University · R01 · FY2021 · AI
Oral Microbiome and Lung Cancer Risk
$630,540Qiuyin Cai · Vanderbilt University Medical Center · R01 · FY2019 · CA
Developmental Core (Core B)
$630,516John Koethe · Vanderbilt University Medical Center · P30 · FY2021 · AI
Mechanism Based Inhibition of M Tuberculosis Enzymes
$630,515Yeshiva University · R01 · FY2002 · AI
SIngle-saMPLE tuberculosis evaluation to facilitate linkage to care: The SIMPLE TB trial
$630,464Adithya Cattamanchi · University Of California, San Francisco · R01 · FY2018 · HL
A Nurse Case Management Intervention to Improve MDR-TB/HIV Coinfection Outcomes
$630,379Jason Edward Farley · Johns Hopkins University · R01 · FY2016 · AI
INNOVATIVE APPROACHES TO TUBERCULOSIS CONTROL
$630,338Johns Hopkins University · U19 · FY2000 · AI
GENETIC FACTORS AND SUSCEPTIBILITY TO TUBERCULOSIS
$630,297Immune Disease Institute, Inc. · R01 · FY2005 · HL
Improving Diagnostics and Neurocognitive Outcomes in HIV/AIDS-related Meningitis
$630,279David R Boulware · University Of Minnesota · R01 · FY2014 · NS
Biotin synthesis and biotin ligation in Mtb
$630,181Dirk Schnappinger · Weill Medical Coll Of Cornell Univ · R01 · FY2011 · AI
An Enhanced Package of Care to Reduce Mortality in Persons with Advanced HIV Disease
$630,069Radha Rajasingham · University Of Minnesota · R01 · FY2023 · AI
Project 4. Defining cell division pathways in Mtb.
$629,949Sabine Ehrt · Weill Medical Coll Of Cornell Univ · P01 · FY2020 · AI
Aerosol spectinamide-1599 therapy against tuberculosis
$629,894Mercedes Gonzalez-Juarrero · Colorado State University · R01 · FY2016 · AI
Fostering resilience to psychosocial and HIV risk in Indian MSM
$629,864Conall Michael O'Cleirigh · Massachusetts General Hospital · R01 · FY2018 · MH
Genetic and metabolic determinants of multiple drug resistance in tuberculosis
$629,809Megan B Murray · Brigham And Women'S Hospital · U19 · FY2008 · AI
Manipulation of the host cell inflammasome by Mycobacterium tuberculosis
$629,786Volker Briken · Univ Of Maryland, College Park · R01 · FY2021 · AI